Add to ORKG• Objective: The aim of our study was to determine susceptibility of linezolid to multi-resistant Mycobacterium tuberculosis isolates. • Material and Method: Seventy two multi drug-resistant Mycobacterium tuberculosis isolates were studied under the activity of 1 µg/ml of linezolid by the BACTEC MGIT 960 susceptibility method. • Results: Seventy two multi drug-resistant Mycobacterium tuberculosis species were determined to be susceptible to linezolid. • Conclusion: Linezolid was found to be effective to multi-resistant Mycobacterium tuberculosis in vitro
The in vitro activity of moxifloxacin, gatifloxacin, levofloxacin and linezolid was evaluated agains...
Tuberculosis is a severe, infectious disease caused by Mycobacterium tuberculosis. The aim of this r...
ABSTRACT Linezolid is an oxazolidinone with potent activity against Mycobacterium tuberculosis. Line...
WOS: 000265293000006Objective: The aim of our study was to determine susceptibility of linezolid to ...
PubMed ID: 19762990We investigated the linezolid susceptibility of Mycobacterium tuberculosis strain...
WOS: 000270557900011PubMed ID: 19762990We investigated the linezolid susceptibility of Mycobacterium...
Objectives: In vitro studies have shown good activity of linezolid against Mycobacterium tuberculosi...
Susceptibility of clinical Mycobacterium tuberculosis isolates to PNU-100480 and linezolid was evalu...
Item does not contain fulltextSusceptibility of clinical Mycobacterium tuberculosis isolates to PNU-...
WOS: 000294274700020Aim: To investigate the in vitro activity of linezolid and ofloxacin in combinat...
Background. Linezolid is a new antibiotic with activity against Mycobacterium tuberculosis in vitro ...
Aim: To investigate the in vitro activity of linezolid and ofloxacin in combination with first-line ...
The management of multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) pre...
WOS: 000251225500006PubMed ID: 18080676The activity of linezolid (Pfizer, USA) was tested by broth m...
The aim of this study is to compare the in vitro activity and minimal inhibitory concentration (MIC)...
The in vitro activity of moxifloxacin, gatifloxacin, levofloxacin and linezolid was evaluated agains...
Tuberculosis is a severe, infectious disease caused by Mycobacterium tuberculosis. The aim of this r...
ABSTRACT Linezolid is an oxazolidinone with potent activity against Mycobacterium tuberculosis. Line...
WOS: 000265293000006Objective: The aim of our study was to determine susceptibility of linezolid to ...
PubMed ID: 19762990We investigated the linezolid susceptibility of Mycobacterium tuberculosis strain...
WOS: 000270557900011PubMed ID: 19762990We investigated the linezolid susceptibility of Mycobacterium...
Objectives: In vitro studies have shown good activity of linezolid against Mycobacterium tuberculosi...
Susceptibility of clinical Mycobacterium tuberculosis isolates to PNU-100480 and linezolid was evalu...
Item does not contain fulltextSusceptibility of clinical Mycobacterium tuberculosis isolates to PNU-...
WOS: 000294274700020Aim: To investigate the in vitro activity of linezolid and ofloxacin in combinat...
Background. Linezolid is a new antibiotic with activity against Mycobacterium tuberculosis in vitro ...
Aim: To investigate the in vitro activity of linezolid and ofloxacin in combination with first-line ...
The management of multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) pre...
WOS: 000251225500006PubMed ID: 18080676The activity of linezolid (Pfizer, USA) was tested by broth m...
The aim of this study is to compare the in vitro activity and minimal inhibitory concentration (MIC)...
The in vitro activity of moxifloxacin, gatifloxacin, levofloxacin and linezolid was evaluated agains...
Tuberculosis is a severe, infectious disease caused by Mycobacterium tuberculosis. The aim of this r...
ABSTRACT Linezolid is an oxazolidinone with potent activity against Mycobacterium tuberculosis. Line...